Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 79,105 | 15,963 | 14,804 | 9,019 | 0 |
| Gross Profit | 79,105 | 15,963 | 14,804 | 9,019 | N/A |
| Operating Expenses | 143,881 | 118,676 | 107,539 | 61,246 | 45,278 |
| Operating Income | -64,776 | -102,713 | -92,735 | -52,227 | -45,278 |
| Other Income | 2,624 | 4,305 | 3,083 | 368 | 399 |
| Pre-tax Income | -62,152 | -98,408 | -89,652 | -51,859 | -44,879 |
| Income Tax | N/A | -774 | 1,099 | -9,050 | -618 |
| Net Income Continuous | -62,152 | -97,634 | -90,751 | -42,809 | -44,261 |
| Net Income | $-62,152 | $-97,634 | $-90,751 | $-42,809 | $-44,261 |
| EPS Basic Total Ops | -21.01 | -44.66 | -47.78 | -28.93 | -30.85 |
| EPS Basic Continuous Ops | -21.06 | -44.64 | -47.78 | -28.95 | -30.85 |
| EPS Diluted Total Ops | -21.01 | -44.66 | -47.78 | -28.93 | -30.85 |
| EPS Diluted Continuous Ops | -21.06 | -44.64 | -47.78 | -28.95 | -30.85 |
| EPS Diluted Before Non-Recurring Items | -21.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-64,098 | $-103,954 | $-92,321 | $-52,008 | $-45,198 |